In the last decade, gender medicine has gained in importance in the management of cardiovascular disease, as several studies demonstrated substantial differences between men and women in terms of disease characteristics, response to treatment and prognosis. However, for most cardiovascular disease, it remains unclear whether this gender difference is due to true biological differences or to a sex bias in medical care, with which women would be less likely to receive appropriate screening and prevention strategies, timely diagnosis and guidelines-based therapy.
In this volume of the European Journal of Preventive Cardiology, Kislitsina et al. 1 compared general disease characteristics, treatment and outcome between men and women undergoing mitral valve surgery and included in the Cardiovascular Research Database of the Clinical Trial Unit of the Bluhm Cardiovascular Institute at Northwestern Memorial Hospital. It is therefore a single centre study, and specifically performed in a tertiary-care referral hospital, whose results might be less representative of the general medical practice as compared with data coming from multi-centre registries, which also reported trends in mitral valve surgery and in post-operative outcome. 2, 3 However, the study population was relatively large (N&1500) and patients were included between 2004 and 2017, therefore well reflecting modern clinical practice and current standard of medical and surgical treatment. Previous studies in fact showed that in the last decades a significant shift in mitral valve disease aetiology has occurred, with less rheumatic mitral valve disease and more frequent degenerative as compared with ischaemic mitral regurgitation; furthermore, surgical techniques have substantially improved, with significantly better post-operative and long-term outcome. 2, 4 It is therefore of clinical importance to assess, as such as in the study of Kislitsina et al., whether gender disparities are still true in the current clinical scenario.
The authors found a significant difference between men and women in the type of surgery (more frequently mitral valve replacement and concomitant atrial fibrillation ablation and tricuspid valve repair in women) and in perioperative complications and mortality (more frequent in women). However, no significant gender differences were observed in mid-term mortality. Baseline characteristics were also significantly different, with women being older, more symptomatic and presenting more frequently with comorbidities and rheumatic valve disease. These observations are well in line with previous studies, 5, 6 which also showed that women are less frequently referred to surgery, and when referred for operation, present more often with mitral valve stenosis, have higher pre-operative risk, more likely to undergo mitral valve replacement (as compared with repair) and have poorer post-operative prognosis. However, in the study by Kislitsina et al., in order to correctly interpret their findings a propensity score matching was performed, including several variables such as age, symptoms, type of mitral valve disease, comorbidities and left ventricular function. As a result, the differences between men and women in terms of surgical treatment and outcome disappeared, even when considering the subgroups of patients with only primary or secondary mitral regurgitation. These findings suggest the following conclusions, which deserve further discussion: 1) the real difference between men and women lies in the clinical characteristic, including mitral valve pathology, at the moment of the referral to surgery, which has significant influence in the choice of the type of surgery; 2) when adjusting for the severity of mitral valve disease and the type of surgery, post-operative and mid-term prognosis of women is comparable to that of men.
According to the present study and to other recent reports, 4 a significant gender difference remains in mitral valve pathology, women still having more rheumatic valve disease than men despite a decrease in the overall incidence of rheumatic disease in the last decades. Also, within patients with a degenerative form of mitral valve disease, men seem to have more frequently single scallop flail while women present with more complex lesions, as also suggested by a large study by the Mayo Clinic. 5 Overall, these gender differences in mitral valve pathology explain the higher chance of mitral valve repair in men and the more frequent mitral valve replacement in women. The type of mitral valve surgery performed has also direct consequences for patient prognosis, since mitral valve replacement has been previously demonstrated to be associated with higher peri-operative complications and lower long-term survival as compared with mitral valve repair. 3 In addition, showing that at the moment of mitral valve surgery women are older, more symptomatic and with higher Society of Thoracic Surgery score despite less coronary artery disease and higher left ventricular ejection fraction, the current study strongly suggests that women are referred to surgery later and at a more advanced stage of the disease. Possible explanations for this late referral in women could be a sex bias of the referring physician, a more aggressive and rapidly progressive form of the mitral valve disease in women, but most probably a true challenge in the assessment of mitral valve disease severity in women. Presence of symptoms is in fact a crucial step in the algorithm of the management of patients with mitral valve disease and specifically in setting the indication for surgical treatment. 7 As for other diseases, women are well known to have different and less clear symptoms, which may therefore delay the decision for surgical treatment. Possibly, the presence of significant comorbidities (i.e. chronic obstructive pulmonary disease) may also complicate the interpretation of the symptoms in terms of their origin (cardiac versus non-cardiac) and severity. Finally, left ventricular dilatation and dysfunction are less easily identified in women when using absolute cut-off values of left ventricular dimensions without correction for body surface area; however, they represent important criteria in the decision making for surgical treatment, 7 and when the volume overload of the left ventricle is not timely recognized may lead to a late referral to surgery and be a possible cause of peri-and post-operative complications and mortality. The study by Kislitsina et al. could not identify the specific reason for the delay in referring women to surgery, but performing the propensity score matching analysis allowed to adjust for most pre-operative differences and showed that surgery was equally performed, based mainly on mitral valve pathology criteria and without any gender bias. Most importantly, when mitral valve surgery was performed, it restored the same life-expectancy between men and women (even without propensity score matching analysis).
The take-home message for the referring physicians and treating cardiologists is therefore to perform in women a careful and customized risk stratification 8 and close follow-up, with possibly early referral for mitral valve surgical treatment in order to avoid the higher peri-and post-operative complications and mortality currently observed as compared with men. The already ongoing large national and international awareness campaigns will, hopefully, help identify the genuine differences between men and women, 9 and specifically in mitral valve pathology, to solve the potential gender difference in the referral to surgery and therefore lead to a significant improvement in the management of women with mitral valve disease.
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